FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Sun Pharmaceutical Industries Metformin HCl Extended-Release Tablets Recall

Metformin HCl Extended-Release Tablets, USP, 500 mg, packaged in 500-count bottles, Rx…

SUN PHARMACEUTICAL INDUSTRIES INC · Princeton, NJ

Risk level
Class II
Reported by FDA
May 19, 2021
Recall ID
D-0372-2021
Check your lot numberHow we source this data

Summary

Sun Pharmaceutical Industries recalled Metformin HCl Extended-Release Tablets starting May 4, 2021. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0372-2021 on May 19, 2021. Reason: Presence of foreign substance: identified as activated carbon. Status: Terminated.

Why it was recalled

Presence of foreign substance: identified as activated carbon.

Product description

Metformin HCl Extended-Release Tablets, USP, 500 mg, packaged in 500-count bottles, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd., Halol-Baroda Highway, Halol-389 350, Gujarat, India, NDC 62756-142-02.

Lot numbers, UPCs & expiration codes

Lots #: JKX2749A, JKX2803A, JKX2804A, JKX2805A, JKX806A, JKX2945A,JKX2946A, JXK2947A, JKX2948A, JKX2952A, JKX2953A, JKX2954A & JKX3224A, Exp 6/2032; JKX3211A, JKX3212A, Exp 7/2023.

Where it was sold

USA Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0372-2021
Classification
Class II
Status
Terminated
Recall initiated
May 4, 2021
FDA report date
May 19, 2021
Quantity
50868 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
SUN PHARMACEUTICAL INDUSTRIES INC

Original FDA data

Every field from FDA enforcement report D-0372-2021, exactly as published.

Show all FDA fields
City
Princeton
State
NJ
Status
Terminated
Country
United States
Event ID
87869
Address
2 Independence Way
Code information
Lots #: JKX2749A, JKX2803A, JKX2804A, JKX2805A, JKX806A, JKX2945A,JKX2946A, JXK2947A, JKX2948A, JKX2952A, JKX2953A, JKX2954A & JKX3224A, Exp 6/2032; JKX3211A, JKX3212A, Exp 7/2023.
Postal code
08540-6620
Report date
May 19, 2021
Product type
Drugs
Recall number
D-0372-2021
Classification
Class II
Recalling firm
SUN PHARMACEUTICAL INDUSTRIES INC
Product quantity
50868 bottles
Termination date
Jun 27, 2023
Reason for recall
Presence of foreign substance: identified as activated carbon.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Metformin HCl Extended-Release Tablets, USP, 500 mg, packaged in 500-count bottles, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd., Halol-Baroda Highway, Halol-389 350, Gujarat, India, NDC 62756-142-02.
Distribution pattern
USA Nationwide
Recall initiation date
May 4, 2021
Initial firm notification
Letter
Center classification date
May 7, 2021

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0372-2021, published May 19, 2021. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls